{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T21:30:56Z","timestamp":1771104656410,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"SingHealth Polyclinics \u2013 Centre Grant","award":["CG21APR3006 (NMRC\/CG3\/001\/2022-SHP)"],"award-info":[{"award-number":["CG21APR3006 (NMRC\/CG3\/001\/2022-SHP)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-025-00442-w","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T09:40:37Z","timestamp":1754041237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carbon emissions from the increasing use of inhaled corticosteroid-LABA medications: a primary care used case from Singapore"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5946-1149","authenticated-orcid":false,"given":"Ngiap Chuan","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Ling Eileen","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi He Mabel","family":"Leow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Keong","family":"Aau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding Xuan","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"442_CR1","doi-asserted-by":"publisher","first-page":"1901872","DOI":"10.1183\/13993003.01872-2019","volume":"55","author":"BI Nwaru","year":"2020","unstructured":"Nwaru, B. I. et al. Overuse of short-acting \u03b22-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur. Respir. J. 55, 1901872, https:\/\/doi.org\/10.1183\/13993003.01872-2019 (2020).","journal-title":"Eur. Respir. J."},{"key":"442_CR2","doi-asserted-by":"publisher","first-page":"2300856","DOI":"10.1183\/13993003.00856-2023","volume":"62","author":"J Vestbo","year":"2023","unstructured":"Vestbo, J. & Press-Kristensen, K. Translated impact on carbon footprint from choice of inhaled therapy: a Danish scenario. Eur. Respir. J. 62, 2300856, https:\/\/doi.org\/10.1183\/13993003.00856-2023 (2023).","journal-title":"Eur. Respir. J."},{"key":"442_CR3","unstructured":"United States Environmental Protection Agency. Control of HFC-23 Emissions, (accessed 25 June 2025); https:\/\/www.epa.gov\/climate-hfcs-reduction\/control-hfc-23-emissions."},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"e001782","DOI":"10.1136\/bmjresp-2023-001782","volume":"11","author":"V Vartiainen","year":"2024","unstructured":"Vartiainen, V. et al. Thoughtful prescription of inhaled medication has the potential to reduce inhaler-related greenhouse gas emissions by 85. BMJ Open Respir. Res 11, e001782, https:\/\/doi.org\/10.1136\/bmjresp-2023-001782 (2024).","journal-title":"BMJ Open Respir. Res"},{"key":"442_CR5","doi-asserted-by":"publisher","first-page":"e001071","DOI":"10.1136\/bmjresp-2021-001071","volume":"8","author":"D Pernigotti","year":"2021","unstructured":"Pernigotti, D. et al. Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries. BMJ Open Respir. Res 8, e001071, https:\/\/doi.org\/10.1136\/bmjresp-2021-001071 (2021).","journal-title":"BMJ Open Respir. Res"},{"key":"442_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s13312-024-3260-7","volume":"61","author":"N Rajvanshi","year":"2024","unstructured":"Rajvanshi, N., Kumar, P. & Goyal, J. P. Global initiative for asthma guidelines 2024: an update. Indian Pediatr. 61, 781\u2013786, https:\/\/doi.org\/10.1007\/s13312-024-3260-7 (2024).","journal-title":"Indian Pediatr."},{"key":"442_CR7","doi-asserted-by":"publisher","first-page":"175346662110425","DOI":"10.1177\/17534666211042534","volume":"15","author":"GW Canonica","year":"2021","unstructured":"Canonica, G. W. et al. Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies. Ther. Adv. Respir. Dis. 15, 17534666211042534 (2021).","journal-title":"Ther. Adv. Respir. Dis."},{"key":"442_CR8","unstructured":"Agency for Care Effectiveness. Inhaled Corticosteroids with Long Acting Beta-2 Agonists for Treating Asthma (accessed 25 June 2025); https:\/\/www.ace-hta.gov.sg\/healthcare-professionals\/ace-technology-guidances\/drug-guidance\/inhaled-corticosteroids-with-long-acting-beta-2-agonists-for-treating-asthma."},{"key":"442_CR9","volume":"37","author":"CD Foo","year":"2023","unstructured":"Foo, C. D. et al. Healthier SG: Singapore\u2019s multi-year strategy to transform primary healthcare. Lancet Reg. Health West. Pac. 37, 100861 (2023).","journal-title":"Lancet Reg. Health West. Pac."},{"key":"442_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2020.100125","volume":"13","author":"M Levin","year":"2020","unstructured":"Levin, M. et al. Acute asthma management during SARS-CoV2-pandemic 2020. World Allergy Organ. J. 13, 100125 (2020).","journal-title":"World Allergy Organ. J."},{"key":"442_CR11","doi-asserted-by":"publisher","first-page":"e064245","DOI":"10.1136\/bmjopen-2022-064245","volume":"14","author":"DHY Tan","year":"2024","unstructured":"Tan, D. H. Y. et al. SABA prescriptions and asthma management practices in Singapore: Results from a cross-sectional, observational SABINA III study. BMJ Open 14, e064245, https:\/\/doi.org\/10.1136\/bmjopen-2022-064245 (2024).","journal-title":"BMJ Open"},{"key":"442_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/thorax-2023-220259","volume":"79","author":"AJK Wilkinson","year":"2024","unstructured":"Wilkinson, A. J. K. et al. Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-based envirONmental cost of treatment (CARBON) study. Thorax 79, 412\u2013421, https:\/\/doi.org\/10.1136\/thorax-2023-220259 (2024).","journal-title":"Thorax"},{"key":"442_CR13","doi-asserted-by":"publisher","first-page":"01009","DOI":"10.1183\/23120541.01009-2024","volume":"11","author":"J Busby","year":"2025","unstructured":"Busby, J. et al. Exploring the carbon footprint of severe asthma and change after biologic therapy initiation: an analysis of Northern Irish data. ERJ Open Res 11, 01009, https:\/\/doi.org\/10.1183\/23120541.01009-2024 (2025).","journal-title":"ERJ Open Res"},{"key":"442_CR14","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1111\/bcp.15135","volume":"88","author":"A Wilkinson","year":"2022","unstructured":"Wilkinson, A. & Woodcock, A. The environmental impact of inhalers for asthma: A green challenge and a golden opportunity. Br. J. Clin. Pharm. 88, 3016\u20133022 (2022).","journal-title":"Br. J. Clin. Pharm."},{"key":"442_CR15","unstructured":"Inhaler carbon footprint comparison tool. National Health System. https:\/\/www.prescqipp.info\/our-resources\/bulletins\/bulletin-295-inhaler-carbon-footprint\/. (Accessed on 25 June 2025)."},{"key":"442_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","volume":"117","author":"M Schatz","year":"2006","unstructured":"Schatz, M. et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J. Allergy Clin. Immunol. 117, 549\u2013556, https:\/\/doi.org\/10.1016\/j.jaci.2006.01.011 (2006).","journal-title":"J. Allergy Clin. Immunol."},{"key":"442_CR17","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.jaip.2021.10.011","volume":"10","author":"HK Reddel","year":"2022","unstructured":"Reddel, H. K. et al. A practical guide to implementing SMART in asthma management. J. Allergy Clin. Immunol. Pract. 10, S31\u2013S38 (2022).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"442_CR18","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1007\/s12325-023-02663-2","volume":"40","author":"A Alzaabi","year":"2023","unstructured":"Alzaabi, A. et al. Greenhouse gas emissions from respiratory treatments: results from the SABA CARBON International Study. Adv. Ther. 40, 4836\u20134856, https:\/\/doi.org\/10.1007\/s12325-023-02663-2 (2023).","journal-title":"Adv. Ther."},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/resp.13804","volume":"25","author":"CR Jenkins","year":"2020","unstructured":"Jenkins, C. R. et al. What have we learnt about asthma control from trials of budesonide\/formoterol as maintenance and reliever?. Respirology 25, 804\u2013815 (2020).","journal-title":"Respirology"},{"key":"442_CR20","doi-asserted-by":"crossref","unstructured":"Metting, E. I. et al. Development of a shared decision-making tool to support patients and their healthcare provider in choosing the best inhaler device. Eur. Respir. J. 52, OA1643 (2018).","DOI":"10.1183\/13993003.congress-2018.OA1643"},{"key":"442_CR21","first-page":"A235","volume":"72","author":"K Liew","year":"2017","unstructured":"Liew, K. & Wilkinson, A. How do we choose inhalers? patient and physician perspectives on environmental, financial and ease-of-use factors. BMJ 72, A235\u2013A237 (2017).","journal-title":"BMJ"},{"key":"442_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/healthcare11081125","volume":"11","author":"MM Alotaibi","year":"2023","unstructured":"Alotaibi, M. M., Hughes, L. & Ford, W. R. Assessing inhaler techniques of asthma patients using aerosol inhalation monitors (AIM): a cross-sectional study. Healthcare 11, 1125, https:\/\/doi.org\/10.3390\/healthcare11081125 (2023).","journal-title":"Healthcare"},{"key":"442_CR23","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1007\/s12325-019-01066-6","volume":"36","author":"ML Levy","year":"2019","unstructured":"Levy, M. L. et al. Understanding dry powder inhalers: key technical and patient preference attributes. Adv. Ther. 36, 2547\u20132557 (2019).","journal-title":"Adv. Ther."},{"key":"442_CR24","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s40273-018-0668-8","volume":"36","author":"CE Rodriguez-Martinez","year":"2018","unstructured":"Rodriguez-Martinez, C. E., Sossa-Brice\u00f1o, M. P. & Castro-Rodriguez, J. A. Cost effectiveness of pharmacological treatments for asthma: a systematic review. Pharmacoeconomics 36, 1165\u20131200 (2018).","journal-title":"Pharmacoeconomics"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00442-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00442-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:17:44Z","timestamp":1757330264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-025-00442-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1038\/s41533-025-00442-w","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethics approval was obtained prior to the commencement of the study (SingHealth Centralized Institutional Review Board Ref No. 2023\/2362).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"36"}}